MRK vs MU: Which Is the Better Buy?
Side-by-side comparison of Merck & Co., Inc. and Micron Technology, Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-04-11.
Merck & Co., Inc. · Healthcare
$121.42
-2.9% upside to fair value
Med Conviction
Grade B
VS
Micron Technology, Inc. · Technology
$421.51
-20.2% upside to fair value
Low Conviction
Grade D
QuantHub Verdict
MRK has more upside to fair value
(-2.9%).
MRK trades at a lower forward P/E
(14.0x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
MRK |
MU |
| Current Price |
$121.42 |
$421.51 |
| Fair Value Estimate |
$118.00 |
$336.45 |
| Upside to Fair Value |
-2.9%
|
-20.2%
|
| Market Cap |
$300.2B |
$475.4B |
| Forward P/E |
14.0x
|
19.7x
|
| EV / EBITDA |
11.8x
|
12.8x
|
| Price / Sales |
4.1x
|
8.2x
|
| Price / FCF |
21.4x
|
21.6x
|
| Revenue Growth YoY |
+1.3%
|
+74.9%
|
| Gross Margin |
81.5%
|
58.4%
|
| Operating Margin |
41.2%
|
48.5%
|
| Return on Equity |
34.7%
|
40.8%
|
| Dividend Yield |
3.1% |
0% |
| FCF Yield |
4.7%
|
4.64%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Merck is a top-5 global pharmaceutical company generating $65B in annual revenue with 81.5% gross margins and 28% net margins. Keytruda, the world's best-selling drug at $31.7B (49% of pharma revenue), faces patent expiry in 2028. Merck is aggressively building replacements through M&A and pipeline launches: Winrevair ($1.4B year one), Capvaxive ($759M), and the $6.7B Terns acquisition for TERN-7…
Micron Technology, Inc. is a leading semiconductor company specializing in memory and storage solutions, including DRAM and NAND products, which are critical for AI, data centers, mobile, and embedded applications. The company benefits from strong revenue growth of 74.9% year-over-year and exceptional profitability with a net margin of 41.5% and return on equity of 40.8%. Despite these strengths …
Accumulation Zones
| Metric |
MRK |
MU |
| Zone Low |
$88.00 |
$252.34 |
| Zone High |
$100.00 |
$285.98 |
| In Buy Zone? |
No
|
No
|